Form 4: Macrogenics Director Margaret Liu Reports Stock Transactions

Director Margaret Liu reports acquisition of shares and restricted stock units in Macrogenics Inc.

Summary

• On May 20, 2025, Margaret Liu, a director of Macrogenics Inc., acquired 6,500 shares of common stock.
• These shares were obtained through the vesting of restricted stock units (RSUs).
• Following this transaction, Liu directly owns 11,000 shares of Macrogenics Inc.
• On May 21, 2025, Liu acquired 3,750 restricted stock units and options to buy 22,000 shares.
• The RSUs will vest one year after the grant date, or the day prior to the next annual meeting, if earlier.
• The options will vest and become exercisable in monthly, cumulative 1/12th increments beginning one month from the date of grant.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard regulatory filing detailing stock transactions by a company director. The transactions themselves don't inherently indicate positive or negative sentiment without further context.

Positives

• The acquisition of shares and RSUs by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Tracking insider transactions is a common practice in financial analysis.
• Comparing the volume and nature of insider transactions (purchases vs. sales) to those of peer companies can provide insights into relative valuation and sentiment.
• However, without additional context (e.g., overall compensation structure, company performance), it's difficult to draw definitive conclusions.

Stakeholder Impact

• The transactions could have a minor impact on shareholders by slightly increasing the number of outstanding shares upon vesting of RSUs and exercise of options.
• The transactions provide transparency to stakeholders regarding insider activity.

Key Dates

Keywords

Macrogenics, Director, Margaret Liu, Stock, RSU, MGNX, Form 4, Beneficial Ownership, Options